Economic implications of inadequate response to erythropoietin in patients with end-stage renal disease

Dialysis and Transplantation

Volumn 26, Issue 10, 1997, Pages 664-669

  Ifudu, Onyekachi ^a   Friedman, Eli A ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CALCIUM CARBONATE; CREATININE; IRON; NITROGEN; RECOMBINANT ERYTHROPOIETIN; UREA;

ANEMIA; ARTICLE; COST BENEFIT ANALYSIS; COST CONTROL; DRUG COST; ECONOMIC ASPECT; HEMATOCRIT; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; UREMIA;

EID: 0030848703     PISSN: 00902934     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Powe NR, Griffiths RI, Bass EB Cost implications to Medicare of recombinant crythropoietin therapy for the anemia of end-stage renal disease.J Am Soc Nephrol 1993; 3:1660-1671.
2. U.S. Renal Data System. USRDS 1995 Annual Data Report Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1995.
3. Ifudu O, Brezsnyak WF, Reydel C, McClendon E, Sugrue T, DiRienzo R, Avram MM, Friedman EA. The pathobiology and functional status of long-term hemodialysis patients. Am J Nephrol 1995; 15:379-385.
4. Ifudu O, Mayers J, Matthew J, Tan CC, Cambridge A, Friedman EA. Dismal rehabilitation in geriatric inner-city hemodialysis patients. JAMA 1994; 271:29-33.
5. Ifudu O, Paul H, Mayers JD, Cohen LS, Brezsnyak WF, Herman AI, Avram MM, Friedman EA. Pervasive failed rehabilitation in center-based maintenance hemodialysis patients. Am J Kidney Dis 1994; 23:394-400.
6. Ifudu O, Feldman J, Friedman EA. The intensity of hemodialysis and the response to erytbropoietin in patients with end-stage renal disease. N Engl J Med 1996; 334:420-425.
7. Sepandj F, Jindal K, West M, Hirsch D. Economic appraisal of maintenance parenteral iron administration in treatment of anemia in chronic hemodialysis patients. Nephrol Dial Transpl 1996; 11:319-322.
8. Fishbane S, Frei GL, Maesaka J. Reduction in recombinant erythropoietin doses by the use of chronic intravenous iron supplementation. Am J Kidney Dis 1995; 26:41-46.